Impaired absorption of insulin aspart from lipohypertrophic injection sites.
about
Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical ExperienceModel study of the pressure build-up during subcutaneous injectionIndian Injection Technique Study: Injecting Complications, Education, and the Health Care ProfessionalDetemir plus aspart and glulisine induced lipoatrophy: 2015 literature review and report of a new caseDeterminants of glycemic control among insulin treated diabetic patients in Southwest Ethiopia: hospital based cross sectional studySurvey of insulin site rotation in youth with type 1 diabetes mellitusThe management of lipohypertrophy in diabetes care.A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes.Frequency of Lipohypertrophy and Associated Risk Factors in Young Patients with Type 1 Diabetes: A Cross-Sectional Study.Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.Unexplained Persistent Hyperglycaemia in a Type I Diabetes Patient - Is Injection Site Lipohypertrophy the Cause?Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?Translating the research in insulin injection technique: implications for practice.Improvement of Insulin Injection Technique: Examination of Current Issues and Recommendations.Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy.Intestinal micropatches for oral insulin delivery.Chronic Toxicology Studies of Basal Insulin Peglispro in Rats and Dogs: A Novel, PEGylated Insulin Lispro Analog with a Prolonged Duration of Action.Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus.Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes.Metabolic consequences of incorrect insulin administration techniques in aging subjects with diabetes.A Randomized Controlled Trial to Assess the Impact of Proper Insulin Injection Technique Training on Glycemic Control.Cautionary tale: subdural haematoma following frequent hypoglycaemia from insulin-induced lipohypertrophy.Converting continuous insulin infusion to subcutaneous insulin glargine after cardiac surgery using percentage-based versus weight-based dosing: a pilot trial.Errors in insulin treatment management and risk of lipohypertrophy.Localized insulin amyloidosis with use of concentrated insulin: a potential complication.The association between insurance coverage for insulin pen needles and healthcare resource utilization among insulin-dependent patients with diabetes in China.Lipohypertrophy in Individuals with Type 2 Diabetes: Prevalence and Risk Factors.Insulin-Related Lipohypertrophy: Lipogenic Action or Tissue Trauma?
P2860
Q28072729-D5AAC918-8D81-4BAC-A240-8423C10475FAQ28085428-921DD0E7-AE85-4C6A-ABC8-05CE22EB0DE9Q28541899-8181B780-1494-475F-8345-49CC78AFFF80Q33732571-5AFC574E-F9A6-4BDA-B7CF-8D2CB11AA285Q33801219-2B0FD850-97A9-4C72-AFD4-67474CA0C24DQ34689252-C77D3240-D7B4-4A8B-8DE1-62A47BA56373Q35819967-40FFAB33-E1CD-44C0-B678-B338FC24D14DQ36841429-FE532BA3-8121-4675-AE8E-AFC5DA79D7E3Q36877074-A111C27A-D1F9-40CC-AB8F-59AA89E50238Q36989672-EA28C470-C511-4BD5-9F5C-3CF8BAA7D106Q37062173-D9303C6C-4FE6-42B9-BEDD-9F1A0871C7EDQ37353075-C0600EF7-B820-489E-BB59-C942AFAC03EEQ37761750-E8E90306-7C5B-48B3-A5F7-E4E91FE5E176Q38034911-3D932111-CE62-4DC6-8DF5-A41FC427B2F2Q38842307-198DB584-C607-4BB9-9C96-B4FD2B35BE18Q38906647-4848E4FE-0B9D-464B-90AD-BCC1B3AF2012Q42045663-C770301B-247B-4A6A-A479-8EF9E07318DDQ42508659-1CB84A37-57D2-4D0B-89EB-7EEA3BC1AA00Q42509025-20B47023-7C73-4AA7-ABBF-F3ECAC21ECDBQ42874244-47808202-2A32-4226-89B0-53158212EEA9Q43989450-F0B55FF8-1BF3-41C6-8BD5-9C6CB950C8B4Q45974578-FFCAFBA6-0FDE-4EF3-BA31-022F2EE044EBQ46188959-E2A2F10B-81A7-458B-9744-6F03C9F33344Q47260325-62AADE8E-493F-467B-BBDF-20F17B8C1733Q47385461-CCB288D8-CB34-4309-883F-5E9B167620ADQ50244058-09765796-2090-47A2-B0EE-A60D171F835DQ52560639-4EE03074-FA97-4A0F-8BCB-05D8C2C332F1Q55424295-010DF479-0AAD-48B8-8BEC-7DD37EC493D2Q58693893-9803491A-8CD4-4C9B-97C5-A9479206D187
P2860
Impaired absorption of insulin aspart from lipohypertrophic injection sites.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Impaired absorption of insulin aspart from lipohypertrophic injection sites.
@en
Impaired absorption of insulin aspart from lipohypertrophic injection sites.
@nl
type
label
Impaired absorption of insulin aspart from lipohypertrophic injection sites.
@en
Impaired absorption of insulin aspart from lipohypertrophic injection sites.
@nl
prefLabel
Impaired absorption of insulin aspart from lipohypertrophic injection sites.
@en
Impaired absorption of insulin aspart from lipohypertrophic injection sites.
@nl
P2093
P1433
P1476
Impaired absorption of insulin aspart from lipohypertrophic injection sites.
@en
P2093
Hans J Arnqvist
Lena Hannerz
Per-Eric Lins
Regina Wredling
Susanne Amsberg
Ulf Adamson
P304
P356
10.2337/DIACARE.28.8.2025
P407
P577
2005-08-01T00:00:00Z